Develops therapies for complement-mediated neuroinflammatory and autoimmune diseases.
| Title |
|---|
| Director, Quality Systems Full Time · $212K-$228K · 10+ YOE Brisbane or United States · Hybrid |
| Vice President, Medical Affairs - Neuroscience Full Time · $354K-$377K · 15+ YOE Brisbane, California, United States · Hybrid |
| Director, Procurement Strategic Contract Negotiator Full Time · $195K-$217K · 10+ YOE Brisbane, California, United States · Hybrid |
| Vice President, Neuroscience - Clinical Development Full Time · $400K-$428K · 15+ YOE Brisbane or San Francisco Bay Area · Onsite |
| Vice President, Ophthalmology Medical Affairs Full Time · $354K-$377K · 15+ YOE Brisbane, California, United States · Hybrid |
| Field Medical Director (MSL) – Ophthalmology (Central Plains Region) Full Time · $190K-$224K · 6+ YOE Brisbane or United States · Remote |
| Associate Director, Clinical Trial Management Full Time · $179K-$200K · 10+ YOE Brisbane, California, United States · Onsite |
| Vice President, Market Access Full Time · $312K-$350K · 15+ YOE Brisbane or San Francisco · Hybrid |
| Senior Director, Clinical Development Full Time · 10+ YOE Brisbane, California, United States · Onsite |
| Activities | Biopharmaceutical researchDrug discoveryClinical drug developmentImmunology researchBiotechnology innovation |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Annexon Biosciences |
| Employees | 118 |
| Type | Public |
| Subsidiaries | Annexon Biosciences Australia Pty Ltd |
| Tagline | Develops therapies for complement-mediated neuroinflammatory and autoimmune diseases. |
| Founded | 2,011 |
| Website | annexonbio.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | ANNX |